These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2476228)

  • 21. Preclinical evaluation of antineoplastic activity of inhibitors of DNA methylation (5-aza-2'-deoxycytidine) and histone deacetylation (trichostatin A, depsipeptide) in combination against myeloid leukemic cells.
    Shaker S; Bernstein M; Momparler LF; Momparler RL
    Leuk Res; 2003 May; 27(5):437-44. PubMed ID: 12620295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological approach for optimization of the dose schedule of 5-Aza-2'-deoxycytidine (Decitabine) for the therapy of leukemia.
    Momparler RL; Côté S; Eliopoulos N
    Leukemia; 1997 Mar; 11 Suppl 1():S1-6. PubMed ID: 9130684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variable DNA methylation changes during differentiation of human melanoma cells.
    Steigerwald SD; Pfeifer GP
    Exp Cell Res; 1988 Sep; 178(1):41-50. PubMed ID: 2457505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of 5-aza-2'-deoxycytidine on differentiation and oncogene expression in the human monoblastic leukemia cell line U-937.
    Attadia V
    Leukemia; 1993 May; 7 Suppl 1():9-16. PubMed ID: 7683359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of cytarabine and decitabine in combination in human leukemic cell lines.
    Qin T; Youssef EM; Jelinek J; Chen R; Yang AS; Garcia-Manero G; Issa JP
    Clin Cancer Res; 2007 Jul; 13(14):4225-32. PubMed ID: 17634552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The DNA methylation system in proliferating and differentiated cells.
    Pfeifer GP; Steigerwald SD; Grünwald S
    Cell Biophys; 1989; 15(1-2):79-86. PubMed ID: 2476229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of deoxycytidine kinase by 5-azacytidine in an HL-60 cell line resistant to arabinosylcytosine.
    Kong XB; Tong WP; Chou TC
    Mol Pharmacol; 1991 Feb; 39(2):250-7. PubMed ID: 1705001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytotoxic activity and mechanism of action of 5-Aza-2'-deoxycytidine in human CML cells.
    Limonta M; Colombo T; Damia G; Catapano CV; Conter V; Gervasoni M; Masera G; Liso V; Specchia G; Giudici G
    Leuk Res; 1993 Nov; 17(11):977-82. PubMed ID: 7694001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of Ley antigen by 5-aza-2'-deoxycytidine in association with differentiation and apoptosis in human pancreatic cancer cells.
    Yamada T; Ohwada S; Saitoh F; Adachi M; Morishita Y; Hozumi M
    Anticancer Res; 1996; 16(2):735-40. PubMed ID: 8687122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of 5-aza-2'-deoxycytidine with amsacrine or 1,25-dihydroxyvitamin D3 on HL-60 myeloid leukemic cells and inhibitors of cytidine deaminase.
    Momparler RL; Doré BT; Labiberté J; Momparler LF
    Leukemia; 1993 May; 7 Suppl 1():17-20. PubMed ID: 7683351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro cytotoxic and biochemical effects of 5-aza-2'-deoxycytidine.
    Momparler RL; Goodman J
    Cancer Res; 1977 Jun; 37(6):1636-9. PubMed ID: 66984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased metallothionein gene expression in 5-aza-2'-deoxycytidine-induced resistance to cadmium cytotoxicity.
    Waalkes MP; Miller MS; Wilson MJ; Bare RM; McDowell AE
    Chem Biol Interact; 1988; 66(3-4):189-204. PubMed ID: 2456160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of the retinoic acid receptor beta gene by 5-aza-2'-deoxycytidine in human DLD-1 colon carcinoma cells.
    Côté S; Momparler RL
    Anticancer Drugs; 1997 Jan; 8(1):56-61. PubMed ID: 9147612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 5-aza-2'-deoxycytidine therapy in patients with acute leukemia inhibits DNA methylation.
    Momparler RL; Bouchard J; Onetto N; Rivard GE
    Leuk Res; 1984; 8(2):181-5. PubMed ID: 6201685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of 5-azacytidine and congeners on DNA methylation and expression of deoxycytidine kinase in the human lymphoid cell lines CCRF/CEM/0 and CCRF/CEM/dCk-1.
    Antonsson BE; Avramis VI; Nyce J; Holcenberg JS
    Cancer Res; 1987 Jul; 47(14):3672-8. PubMed ID: 2439195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of the p53 DNA damage response pathway after inhibition of DNA methyltransferase by 5-aza-2'-deoxycytidine.
    Karpf AR; Moore BC; Ririe TO; Jones DA
    Mol Pharmacol; 2001 Apr; 59(4):751-7. PubMed ID: 11259619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of DNA methylation by 5-aza-2'-deoxycytidine suppresses the growth of human tumor cell lines.
    Bender CM; Pao MM; Jones PA
    Cancer Res; 1998 Jan; 58(1):95-101. PubMed ID: 9426064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potent inhibitors for the deamination of cytosine arabinoside and 5-aza-2'-deoxycytidine by human cytidine deaminase.
    Laliberté J; Marquez VE; Momparler RL
    Cancer Chemother Pharmacol; 1992; 30(1):7-11. PubMed ID: 1375134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacology of 5-Aza-2'-deoxycytidine (decitabine).
    Momparler RL
    Semin Hematol; 2005 Jul; 42(3 Suppl 2):S9-16. PubMed ID: 16015507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of cytidine deaminase by zebularine enhances the antineoplastic action of 5-aza-2'-deoxycytidine.
    Lemaire M; Momparler LF; Raynal NJ; Bernstein ML; Momparler RL
    Cancer Chemother Pharmacol; 2009 Feb; 63(3):411-6. PubMed ID: 18398609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.